Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app help young adults tame type 2 diabetes?

NCT ID NCT07325838

Disease control Sponsor: Recep Turan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 04, 2026 · Updated 3 times

Summary

This study tests a 12-week digital program led by a nurse to help young adults (ages 18-45) with type 2 diabetes better manage their condition. Participants use a web or mobile app for education, goal-setting, and direct messaging with a nurse. The goal is to see if this approach improves blood sugar control, self-care habits, and reduces diabetes-related distress compared to standard care plus digital brochures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Digital nurse-led self-management education and support program
What this could lead to
If successful, this could provide an effective, scalable way to help young adults with type 2 diabetes better manage their condition and reduce diabetes-related distress.
What could go wrong
This is a small, early-stage trial with 72 participants, so results may not apply broadly. The digital program may not be more effective than standard education, and adherence could be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 72 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 45 years. * Diagnosis of Type 2 Diabetes Mellitus. * Able to read and write in the study language. * Has access to the internet and to a digital device (such as a smartphone, tablet, or computer). * No communication barriers (e.g., hearing, speech, or severe cognitive impairment that would prevent understanding of the intervention and questionnaires). * No physical or mental health condition that, in the opinion of the investigators, would prevent participation in the digital intervention and follow-up. * Willing and able to use a digital platform/application for diabetes self-management education and support. * Provides informed consent to participate in the study. Exclusion Criteria: * Diagnosis of Type 1 Diabetes Mellitus or gestational diabetes. * Advanced diabetic retinopathy or other severe visual impairment that significantly limits the ability to use digital devices or read educational materials. * Severe psychiatric disorder or cognitive impairment that would interfere with participation in the intervention or completion of study assessments. * Any condition that the investigators judge to make the person unsuitable for participation (e.g., severe acute illness, terminal condition). * Unwillingness or inability to use the digital platform or to share necessary clinical data for the purposes of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes distress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes distress Diabetes-related distress Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Van Regional Training and Research Hospital, Endocrinology and Metabolism Clinic

    Van, Van, 65150, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.